Aller au contenu principal
Appuyez sur
17/01/2023 - 14:29
HIPRA’s COVID-19 vaccine trial in people with immunocompromising conditions was launched in Turkey
Humain
Explorer
07/11/2022 - 17:20
HIPRA starts a clinical trial to study its vaccine against COVID-19 as a 4th dose
Humain
Explorer
19/07/2022 - 10:14
HIPRA’s COVID-19 vaccine induces a good neutralising antibody response against the BA.2, BA.4 and BA.5 subvariants of Omicron
Humain
Explorer
18/05/2022 - 10:13
HIPRA initiates the first Phase III clinical trial of Covid-19 vaccine in immunocompromised people
Humain
Explorer
29/03/2022 - 14:02
EMA starts rolling review of Covid-19 HIPRA’s vaccine
Humain
Explorer
16/03/2022 - 08:45
GoodGut and Vall d'Hebron Barcelona Hospital are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome
Humain
Explorer
Charger plus